Fosun picks two for $800m Gland Pharma acquisition loan
Shanghai Fosun Pharmaceutical Group has roped in two lenders for an $800m financing to support its acquisition of Indian firm Gland Pharma.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: